As translocations involving EWSR1 and its partner genes are often not specific for tumour types and there is significant morphologic and immunohistochemical overlap between groups of EWSR1-rearranged neoplasms, it is critical that ancillary molecular findings are always evaluated in specific clinical and pathological context. This evidence concerns the gene EWSR1 and neoplasm.